Christopher Jensen

BACKGROUND: The fecal immunochemical test (FIT) is widely used for colorectal cancer (CRC) screening, but there are no published randomized trials or well-designed observational studies on its effectiveness and whether effectiveness varies by cancer location or demographic groups…

Prior studies showed that the benefits, harms, and costs of colorectal cancer (CRC) screening at older ages highly depend on a patient's sex, health, and screening history. However, these studies were not directly informed by stratified data on CRC risk…

BACKGROUND: Prior guidelines recommended initiating colorectal cancer (CRC) screening for average-risk individuals at age 50 years; however, recent guidelines have made qualified recommendations to initiate screening at age 45…